Smith Group Asset Management, LLC Dr Reddys Laboratories LTD Transaction History
Smith Group Asset Management, LLC
- $1.36 Trillion
- Q4 2024
A detailed history of Smith Group Asset Management, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Smith Group Asset Management, LLC holds 43,400 shares of RDY stock, worth $599,788. This represents 0.05% of its overall portfolio holdings.
Number of Shares
43,400Holding current value
$599,788% of portfolio
0.05%Shares
5 transactions
Others Institutions Holding RDY
# of Institutions
253Shares Held
34.9MCall Options Held
12.7KPut Options Held
6.1K-
Robeco Institutional Asset Management B.V.11.4MShares$158 Million0.35% of portfolio
-
Morgan Stanley New York, NY2.24MShares$31 Million0.01% of portfolio
-
Royal Bank Of Canada Toronto, A62MShares$27.6 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.95MShares$27 Million0.25% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$24.9 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.29B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...